Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PDS vs NACT-IDS in Advanced Ovarian Cancer (FOCUS)
NCT04515602Phase 3Not yet recruiting
- Sponsor
- Shanghai Gynecologic Oncology Group
- Start
- Jan 2021
- Primary completion
- Jan 2028
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in epithelial ovarian cancer (EOC), fallopian tube cancer (PFTC) and primary peritoneal carcinoma (PPC), sponsored by Shanghai Gynecologic Oncology Group. Planned start Jan 2021; status: not yet recruiting.
02
Conditions
epithelial ovarian cancer (EOC)fallopian tube cancer (PFTC)primary peritoneal carcinoma (PPC)
Beyond the preview
Go deeper on NCT04515602.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04515602.